These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18958442)

  • 1. [SSRI and SNRI treatment in children and adolescents. Current views of the benefits and risks].
    Holtkamp K; Herpertz-Dahlmann B
    Nervenarzt; 2008 Nov; 79(11):1237-8, 1240, 1243-4, passim. PubMed ID: 18958442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depression in children and adolescents: SSRI can/should be used after individual assessment].
    Melander H; Rastad JA
    Lakartidningen; 2007 Dec; 104(49-50):3798-800; discussion 3800. PubMed ID: 18214330
    [No Abstract]   [Full Text] [Related]  

  • 3. Question: How Should I Switch From One Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) to Another SSRI or SNRI in a Patient With Major Depressive Disorder?
    Rothschild AJ
    J Clin Psychopharmacol; 2024 Sep-Oct 01; 44(5):531-532. PubMed ID: 39173041
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicidality and the use of serotonin reuptake inhibitors.
    Arya DK
    Aust N Z J Psychiatry; 1995 Sep; 29(3):517-8. PubMed ID: 8573060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Still connection between warnings against antidepressive agents to children and adolescents and increased risk of suicide].
    Bejerot S; Isacsson G
    Lakartidningen; 2008 Nov 12-18; 105(46):3361. PubMed ID: 19062631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder.
    Fontenelle LF; Mendlowicz MV; Miguel EC; Versiani M
    World J Biol Psychiatry; 2005; 6(1):57-9. PubMed ID: 16097406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants and suicide attempts in children.
    Cooper WO; Callahan ST; Shintani A; Fuchs DC; Shelton RC; Dudley JA; Graves AJ; Ray WA
    Pediatrics; 2014 Feb; 133(2):204-10. PubMed ID: 24394688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Warning against antidepressive agents has been effective].
    Grøholt B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2652. PubMed ID: 17952145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antidepressive agents to children and adolescents: continuous restriction is justified].
    Högberg G
    Lakartidningen; 2009 Feb 18-24; 106(8):529. PubMed ID: 19350793
    [No Abstract]   [Full Text] [Related]  

  • 13. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.
    Dell'osso B; Mundo E; Marazziti D; Altamura AC
    J Psychopharmacol; 2008 Mar; 22(2):210-3. PubMed ID: 18208931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence for psychopharmacological treatment of depression in children and adolescents?].
    Thomsen PH; Sørensen MJ
    Ugeskr Laeger; 2007 Apr; 169(14):1289-94. PubMed ID: 17437688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
    Khanassov V; Hu J; Reeves D; van Marwijk H
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder.
    Schwartz TL; Nasra GS; Ashton AK; Kang D; Kumaresan H; Chilton M; Bertone F
    Ann Clin Psychiatry; 2007; 19(1):25-30. PubMed ID: 17453658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicide rates and antidepressant prescribing: a casual or causal relationship?
    Baune B; Hay P
    PLoS Med; 2006 Jun; 3(6):e220. PubMed ID: 16752953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs?
    Komaroff AL
    Harv Health Lett; 2012 Aug; 37(10):2. PubMed ID: 22991725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Suicidality in depressive children and adolescents during treatment with selective serotonin reuptake inhibitors. Review and meta-analysis of the available randomised, placebo controlled trials].
    Holtmann M; Bölte S; Poustka F
    Nervenarzt; 2006 Nov; 77(11):1332-7. PubMed ID: 15986258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.